Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), ...

A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo ...

People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical ...

The This Morning presenter, 49, started working with a personal trainer twice a week after discovering she was pre-diabetic ...

A rival drug company is celebrating results claiming its drug helps patients lose more weight than Novo Nordisk’s Wegovy. Eli ...

The continued use of a new obesity treatment can lead to weight loss of up to 23 per cent and a 94 per cent reduction in ...

Obesity is one of the greatest public health issues facing the NHS and weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other ...

With more people taking the weight-loss drugs ... showing that the drug can lower the risk of heart failure and death from ...

Mounjaro will be rolled out gradually as officials said a "difficult decision" had to be made in order to "protect other ...

The sudden explosion in the use of black market weight loss drugs including the diabetes medication Ozempic is the subject of ...

Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47 per cent more weight than those who were given ...